1. Home
  2. AMPH vs CTS Comparison

AMPH vs CTS Comparison

Compare AMPH & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CTS
  • Stock Information
  • Founded
  • AMPH 1996
  • CTS 1896
  • Country
  • AMPH United States
  • CTS United States
  • Employees
  • AMPH N/A
  • CTS N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CTS Electrical Products
  • Sector
  • AMPH Health Care
  • CTS Technology
  • Exchange
  • AMPH Nasdaq
  • CTS Nasdaq
  • Market Cap
  • AMPH 1.6B
  • CTS 1.6B
  • IPO Year
  • AMPH 2014
  • CTS N/A
  • Fundamental
  • Price
  • AMPH $31.28
  • CTS $45.83
  • Analyst Decision
  • AMPH Buy
  • CTS
  • Analyst Count
  • AMPH 4
  • CTS 0
  • Target Price
  • AMPH $50.33
  • CTS N/A
  • AVG Volume (30 Days)
  • AMPH 479.2K
  • CTS 160.0K
  • Earning Date
  • AMPH 03-03-2025
  • CTS 02-04-2025
  • Dividend Yield
  • AMPH N/A
  • CTS 0.35%
  • EPS Growth
  • AMPH 17.38
  • CTS N/A
  • EPS
  • AMPH 3.01
  • CTS 1.89
  • Revenue
  • AMPH $723,549,000.00
  • CTS $515,770,999.00
  • Revenue This Year
  • AMPH $16.22
  • CTS $5.31
  • Revenue Next Year
  • AMPH $4.27
  • CTS $6.01
  • P/E Ratio
  • AMPH $10.39
  • CTS $24.23
  • Revenue Growth
  • AMPH 20.33
  • CTS N/A
  • 52 Week Low
  • AMPH $30.34
  • CTS $42.63
  • 52 Week High
  • AMPH $56.38
  • CTS $59.68
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 25.63
  • CTS 33.18
  • Support Level
  • AMPH $30.34
  • CTS $45.90
  • Resistance Level
  • AMPH $32.40
  • CTS $46.80
  • Average True Range (ATR)
  • AMPH 0.87
  • CTS 1.38
  • MACD
  • AMPH 0.01
  • CTS -0.04
  • Stochastic Oscillator
  • AMPH 23.21
  • CTS 28.65

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan and other countries.

Share on Social Networks: